Citation & Authors
Inflamm Res. 2026;75(1):15.
ABSTRACT · RESEARCH SUMMARY
Research summary
A meta-analysis of 5 real-world cohorts involving 137,640 patients with RA found no significant increase in overall cancer risk with JAK versus TNF inhibitors (HR 1.06; 95% CI 0.81–1.37), but a higher risk of nonmelanoma skin cancer (1.21; 1.03–1.41). GRADE certainty was very low for all findings, which therefore cannot exclude safety concerns in specific high-risk patients.
Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗
